1. Sign our petition calling on Cochrane to withdraw their review of Exercise Therapy for 'CFS'.
    Dismiss Notice
  2. Guest, the 'News in Brief' for the week beginning 10th February 2025 is here.
    Dismiss Notice
  3. Welcome! Read the Core Purpose and Values of our forum.
    Dismiss Notice

trpm

  1. SNT Gatchaman
    Thread

    Broadening the Genetic Spectrum of Painful Small-Fiber Neuropathy through Whole-Exome Study in Early-Onset Cases, 2024, Misra et al.

    Broadening the Genetic Spectrum of Painful Small-Fiber Neuropathy through Whole-Exome Study in Early-Onset Cases Misra, Kaalindi; Ślęczkowska,...
    Thread by: SNT Gatchaman, Jul 4, 2024, 1 replies, in forum: 'Conditions related to ME/CFS' news and research
  2. Andy
    Thread

    Novel characterization of endogenous transient receptor potential melastatin 3 ion channels from Gulf War Illness participants 2024 Marshall-Gradisnik

    Abstract Gulf War Illness (GWI) is a chronic condition characterized by multisystem symptoms that still affect up to one-third of veterans who...
    Thread by: Andy, Jun 26, 2024, 26 replies, in forum: 'Conditions related to ME/CFS' news and research
  3. SNT Gatchaman
    Thread

    Anti-Nociceptive Effects of Sphingomyelinase and Methyl-Beta-Cyclodextrin in the Icilin-Induced Mouse Pain Model, 2024, Horváth et al.

    Anti-Nociceptive Effects of Sphingomyelinase and Methyl-Beta-Cyclodextrin in the Icilin-Induced Mouse Pain Model Horváth, Ádám; Steib, Anita;...
    Thread by: SNT Gatchaman, Apr 25, 2024, 0 replies, in forum: Other health news and research
  4. SNT Gatchaman
    Thread

    Preprint SARS-CoV-2 induces acute neurological signs while CGRP signaling blockade reduces IL-6 release and weight loss in mouse models, 2023, Rahman et al.

    SARS-CoV-2 induces acute neurological signs while Calcitonin Gene-Related Peptide CGRP signaling blockade reduces interleukin 6 IL-6 release and...
    Thread by: SNT Gatchaman, Oct 24, 2023, 1 replies, in forum: Long Covid research
  5. Sly Saint
    Thread

    Altered TRPM7-Dependent Calcium Influx in Natural Killer Cells of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Patients, 2023, du Preez et al

    Abstract: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a disabling multisystemic condition. The pathomechanism of ME/CFS remains...
    Thread by: Sly Saint, Jun 26, 2023, 4 replies, in forum: ME/CFS research
  6. Tom Kindlon
    Thread

    Open Australia: Griffiths Uni: Genotyping analysis in ME/CFS

    Details here: https://www.griffith.edu.au/__data/assets/pdf_file/0022/1574122/Genotyping-analysis-in-ME_CFS.pdf To facilitate sharing: . [MEDIA]
    Thread by: Tom Kindlon, Jul 10, 2022, 1 replies, in forum: Recruitment into current ME/CFS research studies
  7. Sly Saint
    Thread

    Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization w/PIP2 in ME/CFS, 2021, Staines

    Characterization of IL-2 Stimulation and TRPM7 Pharmacomodulation in NK Cell Cytotoxicity and Channel Co-Localization with PIP2 in Myalgic...
    Thread by: Sly Saint, Nov 12, 2021, 1 replies, in forum: ME/CFS research
  8. Sly Saint
    Thread

    Potential Implications of Mammalian Transient Receptor Potential Melastatin 7 in the Pathophysiology of ME/CFS, 2021, Du Preez, Staines et al

    Abstract The transient receptor potential (TRP) superfamily of ion channels is involved in the molecular mechanisms that mediate neuroimmune...
    Thread by: Sly Saint, Oct 13, 2021, 2 replies, in forum: ME/CFS research
  9. Sly Saint
    Thread

    The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in ME/CFS patients 2021, Staines et al

    The effect of IL-2 stimulation and treatment of TRPM3 on channel co-localisation with PIP2 and NK cell function in myalgic...
    Thread by: Sly Saint, Jul 15, 2021, 1 replies, in forum: ME/CFS research
  10. Andy
    Thread

    Potential therapeutic benefit of Low Dose Naltrexone in [ME/CFS]: Role of Transient Receptor Potential Melastatin 3 ion channels, 2021, Cabanas et al

    Full title: Potential therapeutic benefit of Low Dose Naltrexone in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: Role of Transient Receptor...
    Thread by: Andy, Jul 13, 2021, 11 replies, in forum: ME/CFS research
  11. Deleted member 3253
    Thread

    Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in NK cells from ME/CFS patients, Cabanas et al, 2019

    "Naltrexone restores impaired transient receptor potential melastatin 3 ion channel function in natural killer cells from myalgic...
    Thread by: Deleted member 3253, Oct 19, 2019, 47 replies, in forum: ME/CFS research
  12. Andy
    Thread

    Validation of impaired Transient Receptor Potential Melastatin 3 ion channel activity in natural killer cells from CFS/ME, 2019, Cabanas et al

    Background Chronic Fatigue Syndrome/ Myalgic Encephalomyelitis (CFS/ME) is a complex multifactorial disorder of unknown cause having multi-system...
    Thread by: Andy, Apr 25, 2019, 51 replies, in forum: ME/CFS research
Showing results 1 to 12 of 12